↓ Skip to main content

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent

Overview of attention for article published in Cochrane database of systematic reviews, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
7 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
Published in
Cochrane database of systematic reviews, December 2021
DOI 10.1002/14651858.cd011300.pub3
Pubmed ID
Authors

Jianwei Zhu, Yun Yuan, Xiaoyu Wan, Dan Yin, Rui Li, Wenwen Chen, Chen Suo, Huan Song

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 15 16%
Student > Bachelor 8 8%
Other 5 5%
Student > Ph. D. Student 4 4%
Student > Doctoral Student 3 3%
Other 11 11%
Unknown 50 52%
Readers by discipline Count As %
Medicine and Dentistry 19 20%
Unspecified 15 16%
Nursing and Health Professions 7 7%
Psychology 1 1%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 2 2%
Unknown 51 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2022.
All research outputs
#3,244,051
of 25,389,532 outputs
Outputs from Cochrane database of systematic reviews
#5,898
of 11,830 outputs
Outputs of similar age
#74,046
of 518,068 outputs
Outputs of similar age from Cochrane database of systematic reviews
#87
of 162 outputs
Altmetric has tracked 25,389,532 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,830 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,068 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.